Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Breast Cancer

  Free Subscription


Articles published in Am J Clin Oncol

Retrieve available abstracts of 36 articles:
HTML format



Single Articles


    July 2024
  1. PUJARI L, Suresh A, Chowdhury Z, Pradhan S, et al
    Outcomes of De Novo Oligometastatic Breast Cancer Treated With Surgery of Primary and Metastasis Directed Radiotherapy.
    Am J Clin Oncol. 2024 Jul 4. doi: 10.1097/COC.0000000000001129.
    PubMed     Abstract available


  2. QURESHI Z, Altaf F, Jamil A, Siddique R, et al
    Safety and Efficacy of Trastuzumab Deruxtecan for Metastatic HER2+ and HER2-low Breast Cancer: An Updated Systematic Review and Meta-Analysis of Clinical Trials.
    Am J Clin Oncol. 2024 Jul 2. doi: 10.1097/COC.0000000000001126.
    PubMed     Abstract available


    June 2024
  3. QURESHI Z, Jamil A, Fatima E, Altaf F, et al
    Efficacy of Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Comprehensive Systematic Review and Meta-analysis.
    Am J Clin Oncol. 2024 Jun 21. doi: 10.1097/COC.0000000000001121.
    PubMed     Abstract available


  4. QURESHI Z, Jamil A, Altaf F, Siddique R, et al
    Efficacy and Safety of BRCA-targeted Therapy (Polyadenosine Diphosphate-ribose Polymerase Inhibitors) in Treatment of BRCA-mutated Breast Cancer: A Systematic Review and Meta-analysis.
    Am J Clin Oncol. 2024 Jun 20. doi: 10.1097/COC.0000000000001120.
    PubMed     Abstract available


    April 2024
  5. NICHOLSON G, Carlson KB, Hernandez RK, Schenfeld J, et al
    Treatment Patterns of Bone-targeting Agents Among Solid Tumor Patients With Bone Metastases: An Analysis of Electronic Health Record Data in the United States From 2014 to 2018.
    Am J Clin Oncol. 2024;47:177-184.
    PubMed     Abstract available


    March 2024
  6. MISTRY T, Nath A, Pal R, Ghosh S, et al
    Emerging Futuristic Targeted Therapeutics: A Comprising Study Towards a New Era for the Management of TNBC.
    Am J Clin Oncol. 2024;47:132-148.
    PubMed     Abstract available


    December 2023
  7. NING L, Liu Y, He X, Han R, et al
    Validation of CTS5 Model in Large-scale Breast Cancer Population and Combination of CTS5 and Ki-67 Status to Develop a Novel Nomogram for Prognosis Prediction.
    Am J Clin Oncol. 2023 Dec 22. doi: 10.1097/COC.0000000000001080.
    PubMed     Abstract available


  8. SHI M, Li Z, Wang T, Wang M, et al
    Third-line Treatment for Metastatic Triple-negative Breast Cancer: A Systematic Review and Network Meta-analysis.
    Am J Clin Oncol. 2023 Dec 15. doi: 10.1097/COC.0000000000001073.
    PubMed     Abstract available


  9. MCANDREW EN, Graham J, Dufault B, Desautels DN, et al
    Long-term Survival Among Patients With De Novo Human Epidermal Growth Receptor 2-Positive Metastatic Breast Cancer in Manitoba.
    Am J Clin Oncol. 2023 Dec 4. doi: 10.1097/COC.0000000000001068.
    PubMed     Abstract available


  10. MCMURTRY V, Cleary AS, Ruano AL, Lomo L, et al
    Metaplastic Breast Carcinoma: Clinicopathologic Features and Recurrence Score Results From a Population-based Database.
    Am J Clin Oncol. 2023;46:559-566.
    PubMed     Abstract available


    November 2023
  11. MARTINEZ AGUIRRE-BETOLAZA A, Cacicedo J, Castaneda-Babarro A
    Creatine Supplementation and Resistance Training in Patients With Breast Cancer (CaRTiC Study): Protocol for a Randomized Controlled Trial.
    Am J Clin Oncol. 2023 Nov 29. doi: 10.1097/COC.0000000000001070.
    PubMed     Abstract available


  12. SHAIKH PM, Mulherkar R, Khasawneh MT, Clump D, et al
    Treatment of Internal Mammary Nodes is Associated With Improved Overall Survival in Breast Cancer: A Meta-Analysis.
    Am J Clin Oncol. 2023 Nov 2. doi: 10.1097/COC.0000000000001060.
    PubMed     Abstract available


    October 2023
  13. PAN WK, Ren SY, Zhu LX, Lin BC, et al
    A Web-based Prediction Model for Early Death in Patients With Metastatic Triple-negative Breast Cancer.
    Am J Clin Oncol. 2023 Oct 23. doi: 10.1097/COC.0000000000001058.
    PubMed     Abstract available


    September 2023
  14. CHAU B, Loggers ET, Cranmer LD, Mogal H, et al
    Secondary Breast Angiosarcoma After a Primary Diagnosis of Breast Cancer: A Retrospective Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database.
    Am J Clin Oncol. 2023 Sep 19. doi: 10.1097/COC.0000000000001045.
    PubMed     Abstract available


    August 2023
  15. KOPCIK K, Koscielecka K, Krzyzak K
    Cardiac Metastatic Tumors: Current Knowledge.
    Am J Clin Oncol. 2023;46:374-379.
    PubMed     Abstract available


    July 2023
  16. SHUKLA U, Langner UW, Linshaw D, Tan S, et al
    Comparison of Tumor Bed Delineation Using a Novel Radiopaque Filament Marker Versus Surgical Clips for Targeting Breast Cancer Radiotherapy.
    Am J Clin Oncol. 2023 Jul 13. doi: 10.1097/COC.0000000000001028.
    PubMed     Abstract available


    June 2023
  17. FLORES LE, Sargent M, Draeger B, Petereit DG, et al
    Validation of Navigator-Assisted Hypofractionation (NAVAH) Program Survey to Aid American Indian Breast Cancer Patients.
    Am J Clin Oncol. 2023 Jun 9. doi: 10.1097/COC.0000000000001023.
    PubMed    


    March 2023
  18. ABDEL-QADIR H, Thavendiranathan P, Austin PC, Lee DS, et al
    Cardiovascular Diseases Following Breast Cancer: Towards a Case-by-Case Assessment Through a Prediction Risk Score Model in 943 Patients by Benoite M. et al.
    Am J Clin Oncol. 2023;46:129.
    PubMed    


  19. ELAYOUBI J, Chi J, Mahmoud AA, Alloghbi A, et al
    A Review of Endocrine Therapy in Early-stage Breast Cancer: The Journey From Crudeness to Precision.
    Am J Clin Oncol. 2023 Mar 1. doi: 10.1097/COC.0000000000000993.
    PubMed     Abstract available


    January 2023
  20. VALENTE M, Chirico I, Girotti C, Ottoboni G, et al
    The Role of the Quality of Relationship in Couples Facing Treatment for Breast Cancer: A Qualitative Italian Study.
    Am J Clin Oncol. 2023;46:36-42.
    PubMed     Abstract available


  21. VICINI F, Livi L, Pignol JP
    The Cost of Simplicity for Early-stage Breast Cancer Treatment.
    Am J Clin Oncol. 2023;46:1.
    PubMed    


  22. CAMPBELL SR, Shah CS, Sittenfeld SMC, Hoekstra N, et al
    Five Fraction External Beam Partial Breast Irradiation: A User's Guide.
    Am J Clin Oncol. 2023;46:16-19.
    PubMed     Abstract available


  23. CHANG JS, Khan AJ
    Accelerated Partial Breast Irradiation: Technological Advances and Current Challenges.
    Am J Clin Oncol. 2023;46:7-9.
    PubMed     Abstract available


  24. MONTALVO SK, Collins B, Vicini F, Rahimi A, et al
    Stereotactic Partial Breast Irradiation: What Does the Future Hold?
    Am J Clin Oncol. 2023;46:20-24.
    PubMed     Abstract available


  25. MEATTINI I, Kim K, Livi L
    Accelerated Partial Breast Irradiation: Florence Phase 3 Trial Experience and Future Perspectives.
    Am J Clin Oncol. 2023;46:10-15.
    PubMed     Abstract available


  26. SHAH C, Leonardi MC
    Accelerated Partial Breast Irradiation: An Opportunity for Therapeutic De-escalation.
    Am J Clin Oncol. 2023;46:2-6.
    PubMed     Abstract available


    December 2022
  27. FAN Y, Pan X, Yang F, Liu S, et al
    Preoperative Computed Tomography Radiomics Analysis for Predicting Receptors Status and Ki-67 Levels in Breast Cancer.
    Am J Clin Oncol. 2022;45:526-533.
    PubMed     Abstract available


    November 2022
  28. ZHANG ML, Fan YX, Meng R, Cai WK, et al
    Proton Pump Inhibitors and Cancer Risk: An Umbrella Review and Meta-analysis of Observational Studies.
    Am J Clin Oncol. 2022;45:475-485.
    PubMed     Abstract available


    October 2022
  29. ZHOU Q, Zhang Q, Zhao S, Zhang Y, et al
    A Novel Nomogram for Predicting Breast Cancer-specific Survival in Male Patients.
    Am J Clin Oncol. 2022;45:427-437.
    PubMed     Abstract available


  30. TUIA JE, Olivier T, Prasad VK
    Crossover in Adjuvant Trastuzumab Trials: Sparing Toxicity in Patient Care.
    Am J Clin Oncol. 2022;45:438-441.
    PubMed     Abstract available


    August 2022
  31. LOU J, Kooragayala K, Williams JP, Sandilos G, et al
    The Early Impact of the COVID-19 Pandemic on Lung, Colorectal, and Breast Cancer Screening and Treatment at a Tertiary Cancer Center.
    Am J Clin Oncol. 2022 Aug 19. pii: 00000421-990000000-00030.
    PubMed     Abstract available


    July 2022
  32. KWAPISZ D
    Sacituzumab Govitecan-hziy in Breast Cancer.
    Am J Clin Oncol. 2022;45:279-285.
    PubMed     Abstract available


    May 2022
  33. GARBUIO DC, Ribeiro VDS, Hamamura AC, Faustino A, et al
    A Chitosan-Coated Chamomile Microparticles Formulation to Prevent Radiodermatitis in Breast: A Double-blinded, Controlled, Randomized, Phase II Clinical Trial.
    Am J Clin Oncol. 2022;45:183-189.
    PubMed     Abstract available


    April 2022
  34. MERY B, Rowinski E, Rivier C, Bouleftour W, et al
    Cardiovascular Diseases Following Breast Cancer: Towards a Case-by-Case Assessment Through a Prediction Risk Score Model in 943 Patients.
    Am J Clin Oncol. 2022;45:155-160.
    PubMed     Abstract available


    March 2022
  35. OLADERU OT, Ma SJ, Miccio JA, Wang K, et al
    Breast and Cervical Cancer Screening Disparities in Transgender People.
    Am J Clin Oncol. 2022;45:116-121.
    PubMed     Abstract available


    January 2022
  36. ARIANI R, Hwang L, Maliglig AM, Ragab O, et al
    Temporality and Patterns of Metastatic Recurrence in Node-Positive Breast Cancer Following Trimodality Therapy: Opportunity for Improved Oligometastases Detection and Salvage Local Therapy.
    Am J Clin Oncol. 2022 Jan 6. pii: 00000421-900000000-98511.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.